• Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
TheraCryf
  • Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
Mobile close button Mobile toggle button

Evgen Pharma talks through clinical milestones and financial results from its 2022 full-year report

mel | 16 June 2022
Categories: Videos

Post navigation

← Evgen Pharma presents 2022 clinical trials plans and progress with US and UK regulators
Evgen Pharma Post AGM Presentation →
  • Privacy Policy
  • Data Protection Complaints Handling Process
  • Sitemap
Get in touch
LinkedIn

© 2026 TheraCryf. ICO Reg: ZB396415. Company Number: 09246681.